Birkenstock Holding plc
BIRKBirkenstock Holding plc engages in the manufacture and sale of footwear products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It offers footbed-based products, including sandals and closed-toe shoes; and skincare products and accessories.
Company Profile
Financial Snapshot
Shareholder Return
Fiscal 2025
Retired 0.7% of shares last year, 2.1% issued over two.
- Buybacks
- —
- Dividends
- —
What drove EPS
A buyback raises earnings per share without the company earning more. This splits each year's change into the two.
The two parts do not sum exactly to the total — the difference is the cross-term, plus preferred capital where the company has any. It is left visible rather than distributed into the other two.
Share count is the denominator the filer used for diluted EPS, recovered as net income ÷ EPS — not the balance-sheet count, which is a point-in-time figure and would put the timing difference into this split. Years with a loss are omitted: a smaller share count makes a loss per share larger, so the decomposition inverts.
Company Financials
Annual data (10-K) · Last 5 years
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Market Cap | $7.0B | $11.1Best. | $8.5Best. | $7.1Best. | -- |
| Revenue | $2.5B↑22% | $2.0B↑28% | $1.6B↑29% | $1.2B | -- |
| Operating Income | $644.7M↑37% | $470.3M↑71% | $275.4M↓23% | $356.8M | -- |
| Net Income | $408.6M↑91% | $214.0M↑170% | $79.2M↓57% | $183.9M | -- |
| EPS (Diluted) | $2.19↑93% | $1.14↑163% | $0.43↓57% | $1.00 | -- |
| Gross Margin | 59.1%↑1% | 58.8%↓5% | 62.1%↑3% | 60.3% | — |
| Operating Margin | 26.2%↑12% | 23.3%↑34% | 17.5%↓40% | 29.2% | — |
| ROE | 12.8%↑75% | 7.3%↑134% | 3.1%↓61% | 7.9% | — |
| Total Debt | $1.3B↑1% | $1.3B↓32% | $2.0B↑1% | $1.9B | -- |
| Shareholders' Equity | $3.2B↑9% | $2.9B↑16% | $2.5B↑9% | $2.3B↓3% | $2.4B |
| Current Ratio | 2.81↑8% | 2.60↓9% | 2.85↓4% | 2.96 | — |
| Debt / Equity | 0.42↓8% | 0.46↓41% | 0.77↓7% | 0.83 | — |
| Operating Cash Flow | $450.8M↓6% | $478.9M↑26% | $378.9M↑65% | $230.1M | -- |
| Free Cash Flow | $360.8M↓11% | $405.8M↑50% | $271.0M↑69% | $160.6M | -- |
| Metric | Marks Risk-Aware Value | Akre Three-Legged Stool | Druckenmiller Macro-Enhanced Growth | Spier Value Checklist | Pabrai Dhandho Framework | Munger Quality Focus | Ackman Activist Value | Piotroski F-Score | Greenblatt Magic Formula | Lynch GARP | Buffett Quality Compounder | Graham Defensive Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Verdict | HOLD | PASS | BUY | BUY | HOLD | BUY | HOLD | BUY | Not ranked | PASS | FAIL | FAIL |
| Score | ||||||||||||
| Analysis | ||||||||||||
| Intrinsic Value | ||||||||||||
| Margin of Safety | -120.1% | -90.6% | +68.1% | +10.2% | +1.7% | +14.7% | +43.2% | -129.7% | -100.5% | +28.2% | +34.3% | -35.4% |
| Data As Of | 10-K (2026-08-15) | 10-K (2026-08-15) | 10-K (2026-08-15) | 10-K (2026-08-15) | 10-K (2026-08-15) | 10-K (2026-08-15) | 10-K (2026-08-15) | 10-K (2026-08-15) | 10-K (2026-08-15) | 10-K (2026-08-15) | 10-K (2026-08-15) | 10-K (2026-08-15) |
Where They Agree
Where They Disagree
- Profitability
1 of 11 pass — Marks, Akre, Druckenmiller +7 more object
Discount to Intrinsic Value-117.2% (IV=$18.83 vs Price=$40.90)✗Marks>= 20% below intrinsic valuePositive Net Income Frequency4/4 years positive✓MarksPositive net income in >= 7 of last 10 yearsReturn on Equity7.7% (3-yr avg)✗AkreROE > 20% (3-year avg)EPS Growth AccelerationLatest: 92.6%, Prior: 163.1%✗DruckenmillerAccelerating EPS growthShow 19 more metrics ▾Show fewer ▴
Margin of SafetyP/E=18.6x, P/B=2.4x✗SpierP/E < 15 AND P/B < 2.0✗PabraiP/B < 1.5 or P/E < 15Operating Income / Revenue26.2%✓Ackman>= 15%Net Income / Shareholders Equity12.8%✗Ackman>= 15%Net Income / Total Assets7.05%✓PiotroskiROA > 0ROA Change YoY3.92% -> 7.05% (delta: +3.13%)✓PiotroskiCurrent ROA > Prior ROA(CFO / Total Assets) vs ROACFO/Assets=7.78%, ROA=7.05%✓PiotroskiCFO/Assets > ROAGross Margin Change YoY58.8% -> 59.1%✓PiotroskiImproved YoYEBIT / Enterprise Value7.5%✗Greenblatt> 10%Earnings Yield + ROC AssessmentEY=7.5%, ROC=63.4%✗GreenblattBoth EY > 10% and ROC > 25%3-5 Year EPS CAGR29.8%✓Lynch15-30% (Fast Grower); > 0% to passROE12.8%✗Lynch> 15%Net Income Positive (10+ years)4/6 years positive✗BuffettPositive every year for 10+ yearsROE (5-yr avg)7.8%✗Buffett> 15% (5-yr avg)Operating Margin (10-yr trend)26.2% (latest)✓BuffettStable or rising over 10 yearsFree Cash Flow Proxy$451.8M✓BuffettPositive and growingEarnings Variance (10-yr CoV)✗BuffettCoV < 0.3Retained Earnings Effectiveness✗Buffett$1 retained -> > $1 market value createdPositive EPS (10 years)4/6 years positive✗GrahamPositive EPS every year for 10 yearsEPS Growth (3-yr avg, 10-yr window)25.2%✗Graham>= 33% growth - Debt & Leverage
5 of 8 pass — Akre, Lynch and Graham object
Debt Levels0.42✗AkreDebt/Equity < 0.3✓MungerDebt/Equity < 0.5Interest Coverage & Debt/EBITDAIC=6.9x, D/EBITDA=1.7x✓MarksInterest Coverage > 3x; Debt/EBITDA < 4xTotal Debt / Shareholders Equity0.42✓Ackman<= 1.0LT Debt / Total Assets Change23.95% -> 22.82%✓PiotroskiDecreased YoYShow 4 more metrics ▾Show fewer ▴
Total Debt / Equity0.42✗Lynch< 0.33Cash - Long-term Debt$-937.3M✗LynchPositive preferredDebt/Equity & Interest CoverageD/E: 0.42, IC: 6.9x✓BuffettD/E < 0.5 AND Interest Coverage > 5xLT Debt vs Net Current AssetsLT Debt $1.3B vs NCA $964.0M✗GrahamLT Debt <= Net Current Assets - Valuation
4 of 9 pass — Marks, Spier, Pabrai +2 more object
P/B or P/E vs. Historical AverageP/E=18.6x, P/B=2.4x✗MarksP/E < 15 or P/B < 2.0Discount to Intrinsic Value-117.2% (IV=$18.83 vs Price=$40.90)✗Marks>= 20% below intrinsic valuePrice vs. 200-day MAQualitative✓DruckenmillerPrice above 200-day moving averageMargin of SafetyP/E=18.6x, P/B=2.4x✗SpierP/E < 15 AND P/B < 2.0Show 9 more metrics ▾Show fewer ▴
P/E or FCF YieldP/E=18.6x, FCF Yield=4.7%✗PabraiP/E < 15 or FCF Yield > 10%Valuation ReasonablenessP/E=18.6x, OE Yield=5.9%✓MungerP/E < 25 or Owner Earnings Yield > 5%Price / FCF per Share21.1x✓Ackman<= 25EBIT / Enterprise Value7.5%✗Greenblatt> 10%Earnings Yield + ROC AssessmentEY=7.5%, ROC=63.4%✗GreenblattBoth EY > 10% and ROC > 25%P/E / EPS Growth Rate0.63✓Lynch< 1.0 (ideally < 0.5)Price / 3-yr avg EPS32.6x✗Graham<= 15xPrice-to-Book Ratio2.4x✗Graham<= 1.5xP/E x P/B77.80✗Graham<= 22.5 - Cash Flow
4 of 6 pass — Pabrai and Lynch object
FCF Positive4/4 years FCF positive✓MarksPositive FCF in majority of recent yearsP/E or FCF YieldP/E=18.6x, FCF Yield=4.7%✗PabraiP/E < 15 or FCF Yield > 10%(OCF - CapEx) / Market Cap4.7%✓Ackman>= 4%Price / FCF per Share21.1x✓Ackman<= 25Show 4 more metrics ▾Show fewer ▴
Operating Cash Flow$450.8M✓PiotroskiCFO > 0(CFO / Total Assets) vs ROACFO/Assets=7.78%, ROA=7.05%✓PiotroskiCFO/Assets > ROAFCF Positive and Growing$360.8M✗LynchPositive and growingFree Cash Flow Proxy$451.8M✓BuffettPositive and growing - Growth
2 of 5 pass — Druckenmiller, Ackman and Graham object
Positive Net Income Frequency4/4 years positive✓MarksPositive net income in >= 7 of last 10 yearsEPS Growth AccelerationLatest: 92.6%, Prior: 163.1%✗DruckenmillerAccelerating EPS growthRevenue Growth RateLatest: 22.1%, Prior: 27.9%✗DruckenmillerRevenue growth accelerating3yr Median Revenue Growth27.9%✓Ackman>= 5%Show 5 more metrics ▾Show fewer ▴
Positive EPS Growth Frequency2/3 years with positive EPS growth✗AckmanPositive EPS growth in >= 3 of last 5 yearsP/E / EPS Growth Rate0.63✓Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR29.8%✓Lynch15-30% (Fast Grower); > 0% to passInventory Growth vs Revenue GrowthInv: 18.4% vs Rev: 22.1%✓LynchInventory growth < Revenue growthEPS Growth (3-yr avg, 10-yr window)25.2%✗Graham>= 33% growth - Efficiency
3 of 6 pass — Akre, Munger and Buffett object
ROIC (high and growing)0/4 years ROIC > 15% (latest: 11.2%)✗AkreROIC > 15% for 3+ yearsReinvestment Rate x ROIC11.2% (RR=100% x ROIC=11.2%)✓AkreReinvestment Rate * ROIC > 10%Return on Invested Capital11.2%✗Munger> 15%Current Ratio Change YoY2.60 -> 2.81✓PiotroskiIncreased YoYShow 5 more metrics ▾Show fewer ▴
Revenue / Total Assets Change YoY0.37x -> 0.42x✓PiotroskiImproved YoYEBIT / (NWC + Net Fixed Assets)63.4%✓Greenblatt> 25%ROIC (3-5 yr avg)8.6%✗Buffett> 10%ROIC - WACC-1.4%✗BuffettPositive (WACC = 10%)Current Ratio2.81✓Graham>= 2.0 - Verdicts
Split decision: 4 BUY · 3 HOLD · 2 PASS · 2 FAIL
Overall verdict•MarksHOLD (6/8)✓AkrePASS (3/7)✓DruckenmillerBUY (5/7)✓SpierBUY (7/8)•PabraiHOLD (5/8)✓MungerBUY (6/7)•AckmanHOLD (6/9)✓PiotroskiBUY (F-Score 9)•GreenblattNot ranked✓LynchPASS (PEG 0.63)✗BuffettFAIL (3/9)✗GrahamFAIL (2/9) - Valuation models
Models split on BIRK at $39.35 — fair values range $17.13–$123.44
Marks fair value$17.88✗Marks-120.1% margin vs $39.35Akre fair value$20.64✗Akre-90.6% margin vs $39.35Druckenmiller fair value$123.44✓Druckenmiller+68.1% margin vs $39.35Spier fair value$43.80✓Spier+10.2% margin vs $39.35Show 8 more metrics ▾Show fewer ▴
Pabrai fair value$40.03✓Pabrai+1.7% margin vs $39.35Munger fair value$46.15✓Munger+14.7% margin vs $39.35Ackman fair value$69.31✓Ackman+43.2% margin vs $39.35Piotroski fair value$17.13✗Piotroski-129.7% margin vs $39.35Greenblatt fair value$19.63✗Greenblatt-100.5% margin vs $39.35Lynch fair value$54.84✓Lynch+28.2% margin vs $39.35Buffett fair value$59.87✓Buffett+34.3% margin vs $39.35Graham fair value$29.07✗Graham-35.4% margin vs $39.35
Historical Score Timeline
Industry Peers
Similar companies in Apparel
BIRK vs Peers — Financial Grading
| Company | Market Cap | Price | Revenue | Net Income | ROE | D/E | Op. Margin | Curr. Ratio | Graham | Buffett | Lynch | Greenblatt | Piotroski |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CINTAS CORPCTAS | $79.8B | $199.52 | $10.3B | $1.8B | 38.7% | 0.52 | 22.8% | 2.09 | 3/9 | 6/9 | 1/7 | 1/3 | F-Score 5 |
| TAPESTRY, INC.TPR | $25.7B | $128.98 | $7.0B | $183.2M | 21.4% | 2.79 | 5.9% | 1.87 | 1/9 | 4/9 | 1/7 | 0/3 | F-Score 4 |
| RALPH LAUREN CORPRL | $23.2B | $388.92 | $8.1B | $941.1M | 33.1% | 0.44 | 14.5% | 2.13 | 5/9 | 6/9 | 5/7 | 1/3 | F-Score 8 |
| lululemon athletica inc.LULU | $13.6B | $119.55 | $11.1B | $1.6B | 31.8% | — | 19.9% | 2.26 | 3/9 | 3/9 | 3/7 | 3/3 | F-Score 5 |
| DECKERS OUTDOOR CORPDECK | $12.7B | $93.09 | $5.5B | $1.0B | 41.0% | — | 23.1% | 3.54 | 2/9 | 5/9 | 3/7 | 1/3 | F-Score 7 |
| Gildan Activewear Inc.GIL | $10.5B | $56.72 | $3.6B | $398.9M | 11.2% | 1.08 | 17.1% | 2.11 | 3/9 | 6/9 | 1/7 | 0/3 | F-Score 4 |
| LEVI STRAUSS & COLEVI | $8.7B | $22.55 | $6.3B | $578.1M | 25.4% | 0.46 | 10.8% | 1.55 | 3/9 | 5/9 | 2/7 | 1/3 | F-Score 7 |
| Crocs, Inc.CROX | $6.3B | $131.72 | $4.0B | $81.2M | -6.3% | 0.95 | 3.7% | 1.27 | 2/9 | 4/9 | 0/7 | 1/3 | F-Score 5 |